The potential of MMP14 as a prognostic and immune biomarker in lung cancer.

Saved in:
Bibliographic Details
Title: The potential of MMP14 as a prognostic and immune biomarker in lung cancer.
Authors: Xiao J; Hebei North University, Zhangjiakou, Hebei Province, 075000, China., Zhu Z; Hebei North University, Zhangjiakou, Hebei Province, 075000, China.; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250000, China., Zhang F; Department of Pathology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, 075000, China., Wang X; Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, 075000, China. wangxinsheng@hbbfyfy.com.
Source: BMC cancer [BMC Cancer] 2026 Jan 17; Vol. 26 (1), pp. 256. Date of Electronic Publication: 2026 Jan 17.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first